Résultat(s) 1 - 2 résultats de 2 pour la requête 'Niv Y', Temps de recherche: 0,02s Affiner les résultats
  1. 1
    Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial

    Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial par Bekker, P, Petryka, R, Vanasek, T, Niv, Y, Marlicz, K, Haagen-Nielsen, O, Dahelrup, J, Dotan, I, Compel, V, Keshav, S, Schall, T

    Publié 2008
    Conference item
  2. 2
    PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease

    PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease par Keshav, S, Petryka, R, Vanask, T, Niv, Y, Marlicz, K, Haagen-Nielsen, O, Machado, M, Dahlerup, J, Schreiber, S, Bekker, P, Sankar, S, Schall, T

    Publié 2007
    Conference item

Outils de recherche: